Viruses show new promise in treating cancer

September 13, 2018, University of Leeds
Viruses show new promise in treating cancer
This electron microscope image shows white blood cells containing virus particles (shown in red circles). White blood cells can reactivate the virus as it travels to the tumour site, allowing it to retain its cancer-killing ability. Credit: Light and Electron Microscopy Facility, Leiden University Medical Centre

Viruses have shown renewed promise in the treatment of cancer, after new research has shown they retain their cancer-killing ability even when injected into the bloodstream.

The discovery could see used to treat many more patients and a wider range of cancer types than it was previously thought possible.

It is believed that the human body's normal immune response neutralizes viruses that are injected into the bloodstream to try to destroy cancer tumours, during virus .

In a new study investigating reovirus, scientists found that in the blood can reactivate the virus as it travels to the tumour site, allowing it to retain its ability to destroy the .

Viruses generally attack the body and cause harm, but some viruses specifically target and destroy cancer tissue while causing minimal side effects to the patient, making them an attractive new type of cancer treatment, known as oncolytic virus therapy.

Treating skin cancer

A type of virus, called T-vec, is approved on the NHS for advanced melanoma skin cancers and is given to patients by injection directly into their tumours – but this means the tumours have to be somewhere in the body that can be reached with a needle.

Patients receiving injections of virus therapy into the bloodstream in clinical trials quickly developed antibodies which could potentially deactivate the virus, and this was previously believed to stop it functioning.

However, new research shows that white blood cells, which can carry the virus to the tumour site, can also reactivate these deactivated viruses, allowing them to infect and kill the cancer cells.

The study, published in the journal Cancer Immunology Research, was led by Dr. Elizabeth Ilett and Dr. Rob Berkeley from the University of Leeds and Professor Alan Melcher from the Institute of Cancer Research, London.

Dr. Ilett, from the Leeds Institute of Cancer and Pathology at the University, said: "This discovery suggests that cancer treatments using virus therapy could be significantly expanded in future, as we previously believed that follow-up doses were useless once the body had produced antibodies against the virus.

"We are only just beginning to understand how viruses can help us tackle cancer, but it is exciting to learn that our bodies are actually capable of helping them to destroy cancer tumours."

Using antibodies from patients undergoing virus therapy, the researchers neutralized viruses and added them to melanoma cells in the laboratory, which on its own had no effect. But adding white blood cells, called monocytes, meant the virus became reactivated, allowing it to destroy the cancer cells.

The study looked at three different viruses which are currently being used in clinical trials, and found that neutralized forms of two of the three viruses could be reactivated by . The authors believe it is therefore likely that other viruses might also be effective even after being neutralized by antibodies, a finding with immediate clinical significance.

Co-lead author Professor Melcher, said: "Viruses are a hugely exciting new type of treatment for cancer. Not only do virus therapies kill cancer cells directly, they do so with only mild side effects compared to traditional cancer treatments and they attract the immune system to the site of the tumour – which means they can work well when combined with other types of immunotherapy.

"At present, these cancer-killing viruses work really well when injected directly into the site of a tumour – but that means the tumour has to be somewhere in the body that you can reach with a needle.

"Our study shows that, crucially, viruses retain their cancer-killing ability even in the bloodstream. This research has profound implications for how we might use viruses to treat cancer in future, opening up virus therapy to many more patients with hard-to-reach tumours of different types."

Currently, a number of viruses are being tested in clinical trials, but only one virus has been approved for general use, by injection directly to the tumour. The researchers hope that this study will help us gain a better understanding of how therapies work, so that they can be used in combination with other immunotherapies in future.

Explore further: Virus could help treat advanced cancers

Related Stories

Virus could help treat advanced cancers

June 12, 2018
Early results from a small-scale clinical trial have revealed the potential of a virus to treat some advanced cancers.

Fully reprogrammed virus offers new hope as cancer treatment

May 25, 2018
A cancer treatment that can completely destroy cancer cells without affecting healthy cells could soon be a possibility, thanks to research led by Cardiff University.

Link between HPV and cancer after kidney transplant

May 30, 2018
The European Cancer Stem Cell Research Institute at Cardiff University has shed light on the link between skin cancer development and kidney transplants, highlighting the importance for clinicians to monitor transplant patients ...

Virus could treat brain tumours by boosting immune system

January 3, 2018
A virus injected directly into the bloodstream could be used to treat people with aggressive brain tumours, a major new study reports.

Could viruses take cancer immunotherapy to the next level?

January 3, 2018
Immunotherapy, which helps the body's immune system attack cancer, has revolutionized treatment for cancers such as melanoma and leukemia. However, many other kinds of cancer remain resistant. A new study led by researchers ...

Clinical trial uses a genetically engineered virus to fight cancer

August 15, 2017
Sanford Health is the first site in the United States to launch a clinical trial using a genetically-engineered virus that aims to destroy therapy-resistant tumors.

Recommended for you

'Druggable' cancer target found in pathway regulating organ size

November 20, 2018
It's known that cancer involves unchecked cell growth and that a biological pathway that regulates organ size, known at the Hippo pathway, is also involved in cancer. It's further known that a major player in this pathway, ...

Proposed cancer treatment may boost lung cancer stem cells, study warns

November 20, 2018
Epigenetic therapies—targeting enzymes that alter what genes are turned on or off in a cell—are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant. Researchers at Boston ...

Aspirin and omega-3 reduce pre-cancerous bowel polyps

November 19, 2018
Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.

New drug discovery could halt spread of brain cancer

November 19, 2018
The tissues in our bodies largely are made of fluid. It moves around cells and is essential to normal body function.

A molecule for fighting muscular paralysis

November 19, 2018
Myotubular myopathy is a severe genetic disease that leads to muscle paralysis from birth and results in death before two years of age. Although no treatment currently exists, researchers from the University of Geneva (UNIGE), ...

Scientists trained a computer to classify breast cancer tumors

November 19, 2018
Using technology similar to the type that powers facial and speech recognition on a smartphone, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have trained a computer to analyze breast ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.